litlas
ログインアカウント作成

Brian G. Feagan

1993–2025 年に発表

別表記
Brian G Feagan
364
論文数
83,992
被引用数
137
h 指数
342
i10 指数

被引用数

Brian G. Feagan の年別被引用数1982 年: 被引用 1 件1991 年: 被引用 6 件1993 年: 被引用 8 件1994 年: 被引用 3 件1995 年: 被引用 13 件1996 年: 被引用 15 件1997 年: 被引用 21 件1998 年: 被引用 22 件1999 年: 被引用 43 件2000 年: 被引用 44 件2001 年: 被引用 59 件2002 年: 被引用 110 件2003 年: 被引用 135 件2004 年: 被引用 168 件2005 年: 被引用 184 件2006 年: 被引用 304 件2007 年: 被引用 345 件2008 年: 被引用 359 件2009 年: 被引用 399 件2010 年: 被引用 474 件2011 年: 被引用 508 件2012 年: 被引用 417 件2013 年: 被引用 624 件2014 年: 被引用 752 件2015 年: 被引用 799 件2016 年: 被引用 774 件2017 年: 被引用 997 件2018 年: 被引用 1,023 件2019 年: 被引用 3,414 件2020 年: 被引用 3,402 件2021 年: 被引用 2,909 件2022 年: 被引用 2,620 件2023 年: 被引用 2,440 件2024 年: 被引用 3,589 件2025 年: 被引用 1,751 件2026 年: 被引用 42 件1983〜1990 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,305 件、この内訳の 20.5%イギリス: 引用元論文 1,630 件、この内訳の 7.7%カナダ: 引用元論文 1,474 件、この内訳の 7%中国: 引用元論文 1,456 件、この内訳の 6.9%イタリア: 引用元論文 1,303 件、この内訳の 6.2%フランス: 引用元論文 1,101 件、この内訳の 5.2%ドイツ: 引用元論文 1,062 件、この内訳の 5%オランダ: 引用元論文 833 件、この内訳の 4%ベルギー: 引用元論文 743 件、この内訳の 3.5%スペイン: 引用元論文 675 件、この内訳の 3.2%日本: 引用元論文 600 件、この内訳の 2.9%オーストラリア: 引用元論文 554 件、この内訳の 2.6%
0%20.5%その他 25.3%

機関

分野

  • Biochemistry, Genetics and Molecular Biology56.9%
  • Medicine27.9%
  • Immunology and Microbiology9.6%
  • Neuroscience1.2%
  • Nursing1%
  • Agricultural and Biological Sciences0.7%
  • その他2.7%

トピック

  • Inflammatory Bowel Disease20.6%
  • Microscopic Colitis6.9%
  • Rheumatoid Arthritis Research and Therapies4.1%
  • Gut microbiota and health3.4%
  • Autoimmune and Inflammatory Disorders3.1%
  • Biosimilars and Bioanalytical Methods2.4%
  • その他59.5%

共著者

全論文

検索で開く
  1. Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Brian G. Feagan, Paul Rutgeerts, Bruce E. Sands, Stephen B. Hanauer, Jean‐Frédéric Colombel, William J. Sandborn, Gert Van Assche, Jeffrey Axler, Hyo Jong Kim, Silvio Danese, Irving H. Fox, Catherine Milch, Serap Sankoh, Tim Wyant, Jing Xu, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,852

  2. Tofacitinib as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Chinyu Su, Bruce E. Sands, Geert D’Haens, Séverine Vermeire, Stefan Schreiber, Silvio Danese, Brian G. Feagan, Walter Reinisch, Wojciech Niezychowski, Gary S. Friedman, Nervin Lawendy, Dahong Yu, Deborah Woodworth, Arnab Mukherjee, Haiying Zhang, Paul J. Healey, Julián Panés - New England Journal of Medicine 2017 被引用: 1,727

  3. Ustekinumab as Induction and Maintenance Therapy for Crohn’s Disease

    著者: Brian G. Feagan, William J. Sandborn, Christopher Gasink, Douglas Jacobstein, Yinghua Lang, Joshua R. Friedman, Marion Blank, Jewel Johanns, Long-Long Gao, Miao Ye, Omoniyi J. Adedokun, Bruce E. Sands, Stephen B. Hanauer, Séverine Vermeire, Stephan R. Targan, Subrata Ghosh, Willem J. de Villiers, Jean–Frédéric Colombel, Zsolt Tulassay, Ursula Seidler, Bruce Salzberg, Pierre Desreumaux, Scott D. Lee, Edward V. Loftus, Levinus A. Dieleman, Seymour Katz, Paul Rutgeerts - New England Journal of Medicine 2016 被引用: 1,806

  4. Vedolizumab as Induction and Maintenance Therapy for Crohn's Disease

    著者: William J. Sandborn, Brian G. Feagan, Paul Rutgeerts, Stephen B. Hanauer, Jean‐Frédéric Colombel, Bruce E. Sands, Milan Lukáš, Richard N. Fedorak, Scott Lee, Brian Bressler, Irving H. Fox, Maria Rosario, Serap Sankoh, Jing Xu, Kristin Stephens, Catherine Milch, Asit Parikh - New England Journal of Medicine 2013 被引用: 2,687

  5. Infliximab for Induction and Maintenance Therapy for Ulcerative Colitis

    著者: Paul Rutgeerts, William J. Sandborn, Brian G. Feagan, Walter Reinisch, Allan Olson, Jewel Johanns, Suzanne Travers, Daniel Rachmilewitz, Stephen B. Hanauer, Gary R. Lichtenstein, Willem J.S. de Villiers, Daniel H. Present, Bruce E. Sands, Jean‐Frédéric Colombel - New England Journal of Medicine 2005 被引用: 3,883

  6. Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies

    著者: William J. Sandborn, Séverine Vermeire, Laurent Peyrin‐Biroulet, Marla C. Dubinsky, Julián Panés, Andrés Yarur, Timothy E. Ritter, Filip Baert, Stefan Schreiber, Sheldon Sloan, Fabio Cataldi, Kevin Shan, Christopher J. Rabbat, Michael Chiorean, Douglas C. Wolf, Bruce E. Sands, Geert D’Haens, Silvio Danese, Martina Goetsch, Brian G. Feagan - The Lancet 2023 被引用: 333

  7. Ozanimod as Induction and Maintenance Therapy for Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Geert D’Haens, Douglas C. Wolf, Igor Jovanović, Stephen B. Hanauer, Subrata Ghosh, AnnKatrin Petersen, Steven Y. Hua, Ji Hwan Lee, Lorna Charles, Denesh K. Chitkara, Keith Usiskin, Jean–Frédéric Colombel, Loren Laine, Silvio Danese - New England Journal of Medicine 2021 被引用: 532

  8. Risankizumab as induction therapy for Crohn's disease: results from the phase 3 ADVANCE and MOTIVATE induction trials

    著者: Geert D’Haens, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Marc Ferrante - The Lancet 2022 被引用: 387

  9. Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target

    著者: Laurent Peyrin‐Biroulet, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Willem A. Bemelman, Robert V. Bryant, Geert D’Haens, Iris Dotan, Marla C. Dubinsky, Brian G. Feagan, Gionata Fiorino, Richard B. Gearry, Suneeta Krishnareddy, Péter L. Lakatos, Edward V. Loftus, Philippe Marteau, Pia Munkholm, Travis B. Murdoch, Íngrid Ordás, Remo Panaccione, Robert H. Riddell, Joannie Ruel, David T. Rubin, Mark Samaan, Corey A. Siegel, Mark S. Silverberg, Jaap Stoker, S Schreiber, Simon Travis, Gert Van Assche, Silvio Danese, Julián Panés, Guillaume Bouguen, Sarah O’Donnell, Benjamin Pariente, Shawn Winer, Stephen B. Hanauer, J -F Colombel - The American Journal of Gastroenterology 2015 被引用: 1,838

  10. Filgotinib as induction and maintenance therapy for ulcerative colitis (SELECTION): a phase 2b/3 double-blind, randomised, placebo-controlled trial

    著者: Brian G. Feagan, Silvio Danese, Edward V. Loftus, Séverine Vermeire, Stefan Schreiber, Timothy E. Ritter, Ronald Fogel, Rajiv Mehta, Sandeep Nijhawan, Radosław Kempiński, Rafał Filip, Ihor Hospodarskyy, Ursula Seidler, Frank Seibold, Ian Beales, Hyo Jong Kim, John McNally, Chohee Yun, Sally Zhao, Xiaopeng Liu, Chia‐Hsiang Hsueh, Chantal Tasset, R. Besuyen, Mamoru Watanabe, William J. Sandborn, Gerhard Rogler, Toshifumi Hibi∥, Laurent Peyrin‐Biroulet - The Lancet 2021 被引用: 437

  11. Risankizumab as maintenance therapy for moderately to severely active Crohn's disease: results from the multicentre, randomised, double-blind, placebo-controlled, withdrawal phase 3 FORTIFY maintenance trial

    著者: Marc Ferrante, Remo Panaccione, Filip Baert, Peter Bossuyt, Jean–Frédéric Colombel, Silvio Danese, Marla C. Dubinsky, Brian G. Feagan, Tadakazu Hisamatsu, Allen Lim, James O. Lindsay, Edward V. Loftus, Julián Panés, Laurent Peyrin‐Biroulet, Zhihua Ran, David T. Rubin, William J. Sandborn, Stefan Schreiber, Ezequiel Neimark, Alexandra Song, Kristina Kligys, Yinuo Pang, Valerie Pivorunas, Sofie Berg, W. Rachel Duan, Bidan Huang, Jasmina Kalabic, Xiaomei Liao, Anne Robinson, Kori Wallace, Geert D’Haens - The Lancet 2022 被引用: 316

  12. Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial

    著者: Wolfgang Hueber, Bruce E. Sands, Steve Lewitzky, Marc Vandemeulebroecke, Walter Reinisch, Peter Higgins, Jan Wehkamp, Brian G. Feagan, Michael Yao, Marek Karczewski, Jacek Karczewski, Nicole Pezous, Stephan Bek, Gerard Bruin, Bjoern Mellgard, C Berger, Marco Londei, Arthur P. Bertolino, Gervais Tougas, Simon Travis, for the Secukinumab in Crohn's Disease Study Group - Gut 2012 被引用: 1,495

  13. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial

    著者: Stephen B. Hanauer, Brian G. Feagan, Gary R. Lichtenstein, Lloyd Mayer, Stefan Schreiber, Jean‐Frédéric Colombel, Daniel Rachmilewitz, Douglas C. Wolf, Allan Olson, Weihang Bao, Paul Rutgeerts - The Lancet 2002 被引用: 4,163

  14. Guselkumab plus golimumab combination therapy versus guselkumab or golimumab monotherapy in patients with ulcerative colitis (VEGA): a randomised, double-blind, controlled, phase 2, proof-of-concept trial

    著者: Brian G. Feagan, Bruce E. Sands, William J. Sandborn, Matthew Germinaro, Marion Vetter, Jie Shao, Shihong Sheng, Jewel Johanns, Julián Panés, Tkachev Av, Dilara Kalimullina, Robert Petryka, М. Ф. Осипенко, Nataliia Tsarynna, Leonid Bilіanskyi, D Kleczkowski, Andrii Yurkiv, Marek Woynarowski, О. Аbrahamovych, Olha Ivanishyn, Grażyna Rydzewska, Jarosław Kierkuś, Elina Petrova, Olga Vasilevskaya, Halyna Afanasieva, Carlos Fernando de Magalhães Francesconi, Jarosław Leszczyszyn, Elena Bunkova, Dmitry Platonov, Olena Datsenko, Oleksii Gridnyev, Ihor Hospodarsky, Liudmyla Nykodymivna Prystupa, Mykola Stanislavchuk, Anatoly Pershko, О. Б. Щукина, В. И. Симаненков, Oleksandr Golovchenko, William Holderman, Juan S. Lasa, Jakob Begun, Maria de Lourdes de Abreu Ferrari, Pedro López, A. A. Obrezan, Shiraz Farooq, Felix Tiongco, Abel Novillo, Emiliano Tron, Finlay Macrae, Rupert W. Leong, Lígia Yukie Sassaki, Cyrla Zaltman, Roberto Luiz Kaiser, Andreas Stallmach, Jochen Klaus, Manuel Martı́nez, Azalia Ruiz, Р А Абдулхаков, Vishvinder Sharma, Louis Y Korman, James D. Lord, Bhaktasharan Patel, Timothy E. Ritter - ˜The œLancet. Gastroenterology & hepatology 2023 被引用: 224

  15. Gut Microbiome Composition Is Associated With Future Onset of Crohn’s Disease in Healthy First-Degree Relatives

    著者: Juan A. Raygoza Garay, Williams Turpin, Sun-Ho Lee, Michelle I. Smith, Ashleigh Goethel, Anne M. Griffiths, Paul Moayyedi, Osvaldo Espin‐Garcia, Maria Abreu, Guy Aumais, Çharles N. Bernstein, I Avni Biron, Maria Cino, Colette Deslandres, Iris Dotan, Wael El-Matary, Brian G. Feagan, David S. Guttman, Hien Q. Huynh, Levinus A. Dieleman, Jeffrey S. Hyams, Kevan Jacobson, David Mack, John K. Marshall, Anthony Otley, Remo Panaccione, Mark J. Ropeleski, Mark S. Silverberg, A. Hillary Steinhart, Dan Turner, Baruch Yerushalmi, Andrew D. Paterson, Wei Xu, Maria Abreu, Paul L. Beck, Çharles N. Bernstein, Kenneth Croitoru, Levinus A. Dieleman, Brian G. Feagan, Anne M. Griffiths, David S. Guttman, Kevan Jacobson, Gilaad G. Kaplan, Denis O. Krause, Karen Madsen, John K. Marshall, Paul Moayyedi, Mark J. Ropeleski, Ernest G. Seidman, Mark S. Silverberg, Scott B. Snapper, Andy Stadnyk, Hillary Steinhart, Michael G. Surette, Dan Turner, Tom Walters, Bruce A. Vallance, Guy Aumais, Alain Bitton, Maria Cino, Jeff Critch, Lee A. Denson, C Deslandres, Wael El-Matary, Hans Herfarth, Peter Higgins, Hien Q. Huynh, Jeffrey S. Hyams, David Mack, Jerry McGrath, Anthony Otley, Remo Panancionne, Kenneth Croitoru - Gastroenterology 2023 被引用: 192

  16. IL-12 and IL-23 pathway inhibition in inflammatory bowel disease

    著者: Bram Verstockt, Azucena Salas, Bruce E. Sands, Clara Abraham, Haim Leibovitzh, Markus F. Neurath, Niels Vande Casteele, Silvio Danese, Geert D’Haens, Lars Eckmann, William A. Faubion, Brian G. Feagan, Vipul Jairath, Christopher Ma, Saurabh Mehandru, Julián Panés, Florian Rieder, William J. Sandborn, Mark S. Silverberg, Marisol Veny, Séverine Vermeire, Stefania Vetrano - Nature Reviews Gastroenterology & Hepatology 2023 被引用: 231

  17. Global burden of inflammatory bowel disease

    著者: Vipul Jairath, Brian G. Feagan - ˜The œLancet. Gastroenterology & hepatology 2019 被引用: 363

  18. Subcutaneous Golimumab Induces Clinical Response and Remission in Patients With Moderate-to-Severe Ulcerative Colitis

    著者: William J. Sandborn, Brian G. Feagan, Colleen Marano, Hongyan Zhang, Richard Strauß, Jewel Johanns, Omoniyi J. Adedokun, Cynthia Guzzo, Jean‐Frédéric Colombel, Walter Reinisch, Peter R. Gibson, Judith Collins, Gunnar Järnerot, Toshifumi Hibi∥, Paul Rutgeerts - Gastroenterology 2013 被引用: 928

  19. Efficacy and Safety of Upadacitinib in a Randomized Trial of Patients With Crohn’s Disease

    著者: William J. Sandborn, Brian G. Feagan, Edward V. Loftus, Laurent Peyrin‐Biroulet, Gert Van Assche, Geert D’Haens, Stefan Schreiber, Jean‐Frédéric Colombel, James D. Lewis, Subrata Ghosh, Alessandro Armuzzi, Ellen Scherl, Hans Herfarth, L.M. Vitale, Mohamed‐Eslam F. Mohamed, Ahmed A. Othman, Qian Zhou, Bidan Huang, Roopal Thakkar, Aileen L. Pangan, Ana P. Lacerda, Julián Panés - Gastroenterology 2020 被引用: 317

  20. Ustekinumab Induction and Maintenance Therapy in Refractory Crohn's Disease

    著者: William J. Sandborn, Christopher Gasink, Long-Long Gao, Marion Blank, Jewel Johanns, Cynthia Guzzo, Bruce E. Sands, Stephen B. Hanauer, Stephan R. Targan, Paul Rutgeerts, Subrata Ghosh, Willem J.S. de Villiers, Remo Panaccione, Gordon R. Greenberg, Stefan Schreiber, Simon Lichtiger, Brian G. Feagan - New England Journal of Medicine 2012 被引用: 1,128

  21. Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

    著者: William J. Sandborn, Geert D’Haens, Walter Reinisch, Julián Panés, Daphne Chan, Susana Gonzalez, Kathleen Weisel, Matthew Germinaro, Mary Ellen Frustaci, Zijiang Yang, Omoniyi J. Adedokun, Chenglong Han, Remo Panaccione, Tadakazu Hisamatsu, Silvio Danese, David T. Rubin, Bruce E. Sands, Anita Afzali, Jane M. Andrews, Brian G. Feagan - Gastroenterology 2022 被引用: 198

  22. Infliximab Maintenance Therapy for Fistulizing Crohn's Disease

    著者: Bruce E. Sands, Frank Anderson, Çharles N. Bernstein, William Y. Chey, Brian G. Feagan, Richard N. Fedorak, Michael A. Kamm, Joshua R. Korzenik, Bret A. Lashner, Jane E. Onken, Daniel Rachmilewitz, Paul Rutgeerts, Gary Wild, Douglas C. Wolf, P Marsters, Suzanne Travers, Marion Blank, S J van Deventer - New England Journal of Medicine 2004 被引用: 2,221

  23. C-Reactive Protein, Fecal Calprotectin, and Stool Lactoferrin for Detection of Endoscopic Activity in Symptomatic Inflammatory Bowel Disease Patients: A Systematic Review and Meta-Analysis

    著者: Mahmoud Mosli, Guangyong Zou, Sushil Kumar Garg, Sean Feagan, John K MacDonald, Nilesh Chande, William J. Sandborn, Brian G. Feagan - The American Journal of Gastroenterology 2015 被引用: 682

  24. Developing an instrument to assess the endoscopic severity of ulcerative colitis: the Ulcerative Colitis Endoscopic Index of Severity (UCEIS)

    著者: Simon Travis, Dan Schnell, Piotr Krzeski, María T. Abreu, Douglas G. Altman, Jean–Frédéric Colombel, Brian G. Feagan, Stephen B. Hanauer, Marc Lémann, Gary R. Lichtenstein, Phillippe R Marteau, Walter Reinisch, Bruce E. Sands, Bruce Yacyshyn, Christian A. Bernhardt, Jean‐Yves Mary, William J. Sandborn - Gut 2011 被引用: 626